Another study detected deleterious variants in FURIN, also including rs6226, suggesting a decrease in FURIN protease function that potentially can reduce the risk of SARS-CoV-2, which may explain COVID-19 clinical disparity in Middle Eastern populations (Kuwait, Qatar, and Iran) [7]. Here, FURIN is linked to COVID-19.